Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement in transplant rejection: diagnostic and mechanistic considerations.

William M Baldwin1, Hirofumi Ota, E Rene Rodriguez

  • 1Department of Pathology, Ross Research Bldg., Room 659, The Johns Hopkins University School of Medicine, 720 Rutland Avenue, Baltimore, MD 21205, USA.

Springer Seminars in Immunopathology
|September 5, 2003
PubMed
Summary

Complement, a key inflammation mediator, is crucial in organ transplant rejection. Understanding its complex role aids in diagnostics and improving transplant outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of concomitant chemotherapy on edoxaban plasma concentration in patients with colorectal cancer.

BMC gastroenterology·2026
Same author

Relationship between body segment movements and center of pressure shifts during trunk lean movements while sitting in healthy adults.

Frontiers in rehabilitation sciences·2026
Same author

Novel Mechanism of and Therapeutic Approach for Anthracycline-Induced Cardiotoxicity.

Cancer research communications·2026
Same author

Intraoperative Evaluation of Bladder Perfusion Using Indocyanine Green Fluorescence Imaging During Total Pelvic Exenteration After Interruption of Blood Flow From the Internal Iliac Vessels.

Annals of gastroenterological surgery·2026
Same author

Phase II study of maintenance trifluridine/tipiracil (TAS-102) plus bevacizumab after induction chemotherapy in metastatic colorectal cancer.

The oncologist·2026
Same author

First-line FOLFOXIRI-based Chemotherapy for Unresectable Metastatic Colorectal Cancer: Real-world Outcomes, Safety, and Conversion Surgery.

Anticancer research·2026

Area of Science:

  • Immunology
  • Transplantation Biology

Background:

  • Complement has re-emerged as a critical factor in organ transplantation.
  • Increased use of extended criteria donors and recipients (e.g., older donors, presensitized recipients) elevates complement activation risks.

Purpose of the Study:

  • To highlight the significance of complement in organ transplant rejection.
  • To underscore the diagnostic and mechanistic implications of complement activation.

Main Methods:

  • Review of current understanding of complement biology in transplantation.
  • Analysis of complement's role in innate and adaptive immune responses.
  • Examination of complement's impact on endothelial cells and apoptotic cell clearance.

Main Results:

Related Experiment Videos

  • Complement components are increasingly recognized as diagnostic indicators of transplant inflammation and rejection.
  • Evidence of complement activation is more frequently detected in biopsy samples.
  • Complement effector molecules mediate pro-inflammatory functions and disrupt the endothelial interface.

Conclusions:

  • Understanding complement biology is vital for interpreting its role in organ transplant rejection.
  • Complement activation by various mechanisms influences transplant outcomes.
  • Complement plays a multifaceted role, modulating transplant responses in diverse ways.